Combined effect of intravitreal faricimab and direct photocoagulation for focal diabetic macular edema

Combined effect of intravitreal faricimab and direct photocoagulation for focal diabetic macular edema - Combined effect of intravitreal faricimab and direct photocoagulation for focal diabetic macular edema

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059235

Enrollment

Registered

2025-10-01

Start date

2025-09-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macular edema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with focal DME who required anti-VEGF treatment with faricimab and retinal photocoagulation at our hospital from June 1, 2022

Exclusion criteria

Exclusion criteria: 1. If the subject refuses to participate in the study 2. If the principal investigator (sub-investigator) otherwise determines that the subject is unsuitable as a subject

Design outcomes

Primary

Measure	Time frame
Area of edema of 500 micrometer or more on OCT map corrected visual acuity central retinal thickness	—

Secondary

Measure	Time frame
Number of faricimab injections	—

Countries

Japan

Contacts

Public Contactyuki sanada

university of Fukui Hospital Ophthalmology

akasakasakasusa@gmail.com0776-61-8403

Outcome results